BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8457636)

  • 1. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the sequence of fibrinopeptide A cleavage from fibrinogen fragment E by thrombin, atroxin, or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Thromb Res; 1993 Jun; 70(6):437-49. PubMed ID: 8362369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen Zürich I: defective fibrinopeptide-A release].
    Hofmann V; Gati WP; Straub PW
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1468. PubMed ID: 918602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel variant fibrinogen, AαE11del, demonstrating the importance of AαE11 residue in thrombin binding.
    Kaido T; Yoda M; Kamijo T; Arai S; Yamauchi K; Okumura N
    Int J Hematol; 2021 Nov; 114(5):591-598. PubMed ID: 34333754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
    Halvorsen S; Skjønsberg OH; Godal HC
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
    Soya K; Takezawa Y; Terasawa F; Okumura N
    Rinsho Byori; 2012 Jun; 60(6):499-505. PubMed ID: 22880226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombin-fibrinogen interaction.
    Scheraga HA
    Biophys Chem; 2004 Dec; 112(2-3):117-30. PubMed ID: 15572239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.